Blue Owl Capital Holdings’s Repare Therapeutics RPTX Stock Holding History

Blue Owl Capital Holdings’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,443,659	Closed	-$8.95M	–	90
2025 Q4	$8.95M	Hold	3,443,659	–	–	2.76%	10
2025 Q3	$6.06M	Hold	3,443,659	–	–	1.88%	18
2025 Q2	$4.79M	Hold	3,443,659	–	–	1.54%	19
2025 Q1	$3.4M	Hold	3,443,659	–	–	1.09%	23
2024 Q4	$4.51M	Buy	3,443,659 +71,160	+2%	+$212K	1.04%	22
2024 Q3	$11.6M	Hold	3,372,499	–	–	2.24%	13
2024 Q2	$11.1M	Buy	3,372,499 +250,000	+8%	+$892K	3.1%	10
2024 Q1	$14.7M	Hold	3,122,499	–	–	2.94%	11
2023 Q4	$22.8M	Buy	+3,122,499	New	+$17.5M	5.45%	7

Blue Owl Capital Holdings's RPTX Position: Q1 2026 in Review

Blue Owl Capital Holdings sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 3,443,659 shares — an estimated $8.95M sold.

Blue Owl Capital Holdings first reported a position in RPTX in Q4 2023 and held it in 9 quarters. The position peaked at $22.8M in Q4 2023. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

Blue Owl Capital Holdings reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
Blue Owl Capital Holdings sold 3,443,659 Repare Therapeutics shares in Q1 2026, an estimated $8.95M.
Blue Owl Capital Holdings first reported a position in Repare Therapeutics in Q4 2023 and held it in 9 quarters.
Blue Owl Capital Holdings's Repare Therapeutics position peaked at $22.8M in Q4 2023.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on Blue Owl Capital Holdings's 13F filing for Q1 2026, filed 14 May 2026.